| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,792 |
9,232 |
$670K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,046 |
7,553 |
$610K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,781 |
5,671 |
$441K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,349 |
2,305 |
$200K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,660 |
4,456 |
$31K |
| 99000 |
|
3,724 |
3,546 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,109 |
1,012 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
803 |
770 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
484 |
457 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
22 |
21 |
$1K |
| 81003 |
|
470 |
444 |
$611.60 |
| 87807 |
|
45 |
44 |
$475.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
233 |
223 |
$183.95 |
| 99072 |
|
613 |
561 |
$46.00 |
| A9150 |
Non-prescription drugs |
12 |
12 |
$3.50 |
| S9083 |
Global fee urgent care centers |
14 |
13 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
12 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
43 |
37 |
$0.00 |